The Omission of Axillary Lymph Node Dissection in Sentinel Node-Positive Breast Cancer Patients Requires Careful Consideration
Journal Title: International Journal of Cancer and Clinical Research - Year 2017, Vol 4, Issue 2
Abstract
Sentinel Node Biopsy (SNB) is used to accurately assess axillary lymph node status in patients with node-negative breast cancer. The purpose of this study was to assess the association between Non-Sentinel Node (SN) metastasis and clinicopathological findings in patients with one or two SN-positive breast cancer. We evaluated 132 patients with one or two SN-positive breast cancer and 25 patients (19%) had metastatic non-SNs. Positive non-SN metastasis was associated with the HER2 positive (P = 0.035), tumor size (P = 0.06) and equal number of excisional SN and positive SN (P = 0.003). When considering omitting the dissection in SN-positive patients, it is essential to carefully consider the number of removed SNs. Moreover, particular caution is required when considering whether to omit the dissection in patients with tumors exhibiting diameters of > 2 cm or HER2-overexpressing.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP352237
- DOI 10.23937/2378-3419/1410086
- Views 142
- Downloads 0
Immune Paralysis and the Spontaneous Remission of Cancer
Once a malignant growth grows past a certain size immune tolerance rather than immune sensitization occurs possibly due to the slow tumor growth. As the malignant grows larger some branches of the immune system (adoptive...
Assessing Response to Chemoradiotherapy on 18F-FDG PET Images in Non-Small Cell Lung Cancer using New Approaches of Histogram and Gray Level Co-Occurrence Matrix
Purpose To investigate inherent information provided by 18F-FDG PET to ameliorate shortcomings of relying on visual inspection or sole SUV measurement in treatment assessing. Patients and methods Twelve patients with ne...
Acetylation of α-tubulin by a Histone Deacetylase Inhibitor, Resminostat, Leads Synergistic Antitumor Effect with Docetaxel in Non-Small Cell Lung Cancer Models
Background: There is a growing body of clinical evidence to demonstrate that inhibition of histone deacetylase is effective in the treatment of various types of cancer. We examined whether acetylation of a non-histone pr...
Clinical Utility of Serum Human Epidermal Growth Factor Receptor Type 2 Testing as a Marker of Therapeutic Response In Tissue HER2-Positive Breast Cancer Patients
Background Human Epidermal growth factor Receptor type 2 (HER2) is over expressed in 20.0-30.0% of breast cancers and is currently evaluated histopathologically. Immunohistochemistry and fluorescence in situ hybridizatio...
Angiogenesis Inhibitor Induced Thromboembolism in Cancer Patients
Therapy with Angiogenesis Inhibitors (AIs) is a newer targeted approach in treating cancers. It gained popularity in the past decade because of better outcomes and fewer side effects when compared to conventional chemoth...